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Tennessee College of Veterinary Medicine •  Knoxville, TN 37996
ABSTRACT
A simple, easy, and accurate high-performance liquid chromatographic method for 
the determination of fentanyl concentrations in plasma samples has been developed 
and validated. Following a liquid extraction with acetonitrile, samples were separated 
by reversed-phase high-performance liquid chromatography (HPLC) on an XBridge C18
column (2.1 x 50 mm, 3.5µm) and detected by mass spectroscopy. The mobile phase 
was a mixture of water with 0.1% formic acid, and acetonitrile with 0.1% formic acid 
(90:10), with a flow rate of 0.6 ml/min. The procedure produced a linear curve over 
the concentration range of 0.1-25 ng/ml for fentanyl in canine plasma with a LOQ of 
0.1 ng/ml. Intra- and inter-assay variability ranged from 2.6%-8.2% and the average 
recovery for fentanyl was 100%.
INTRODUCTION
Fentanyl, N-(1-phenethyl-4-piperidyl) propionanilide, is a synthetic opioid which has 
a high affinity for µ-opioid receptors. Fentanyl injection and transdermal patches are 
used primarily in dogs and cats and have been shown to be useful for the adjunctive 
control of postoperative pain and in the control of severe pain associated with chronic 
pain, dull pain, and non-specific, widespread pain associated with cancer, pancreatitis, 
aortic thromboemboli, and peritonitis. Perioperative injectable fentanyl may also 
reduce the requirements for inhalational anesthetics during surgery, which could be 
particularly advantageous in patients with compromised cardiac function.  Fentanyl 
levels have been determined using mass spec and ultraviolet detection in plasma 
blood, urine, and saliva. Many extraction methods have been reported including solid 
phase extraction, and liquid-liquid extractions. This paper describes a simple, sensitive, 
and accurate method for extracting fentanyl from plasma samples using HPLC.
Intra assay  variability (n=5)
Concentration
(ng/ml)
Concentration measured
(ng/ml)
(mean ± SD)
RSD
(%)
0.3 0.3 ± 0.02 6.6
0.75 0.73 ± 0.05 7
17.5 17.8 ± 0.58 3
Inter assay variability (n=5)
Concentration
(ng/ml)
Concentration measured
(ng/ml)
(mean ± SD)
RSD
(%)
0.3 0.28 ± 0.02 7.5
0.75 0.77 ± 0.06 8.2
17.5 17.0 ± 0.44 2.6
Sample Treatment
Fentanyl was extracted from plasma samples using a liquid extraction with 
acetonitrile. Previously frozen plasma samples were thawed and vortexed and 100 µl 
was transferred to a 7 ml glass screw top tube then 25 µl of internal standard (0.1 
µg/ml flurazepam) added. One milliliter of acetonitrile was added and tubes were 
capped and vortexed for 60 s then centrifuged for 20 min at 1020 x g. The 
supernatant was removed and placed in a clean glass tube and evaporated to 
dryness with nitrogen gas. Samples were reconstituted in 200 µl of mobile phase and 
50 µl injected into the HPLC system.
MATERIALS and METHODS
Reagents and Standards 
Fentanyl was purchased from USP. Flurazepam, the internal standard, was 
purchased from Cerilliant. All reagent grade chemicals and solvents were purchased 
from Fisher Scientific. Water (18.2 megaohm) was obtained from a Barnstead 
Micropure Infinity  ultrapure water system. Stock solutions of fentanyl and flurazepam 
(100 µg/ml) were prepared in methanol. Dilutions were prepared to produce working 
stock standards of 0.01, 0.1, and 1 µg/ml. The standards were stored at 4°C and were 
stable for a minimum of 6 months. Standard curves for plasma were prepared by 
spiking untreated plasma with fentanyl which produced a linear concentration range 
of 0.1 to 25 ng/ml. Spiked standards were treated exactly as plasma samples.
For stability testing, canine plasma (400 µL) was spiked with fentanyl at 
concentrations 0.3, 0.75, and 17.5 ng/ml. A 100 µL sample was pulled from this spiked 
plasma and analyzed immediately. The remaining spiked plasma was then frozen in an 
-80˚C freezer, thawed, and another 100 µL sample was analyzed. This process was 
repeated for a total of three freeze-thaw cycles. The results were then compared to 
the initial analysis. 
RESULTS and CONCLUSIONS
Testing of blank and spiked canine plasma revealed no interferences for fentanyl 
or flurazepam. Figs. 1 & 2 show chromatograms of a (A) blank plasma sample,  (B) a 
2.5 ng/ml spiked dog plasma standard and (C) a dog plasma sample after fentanyl 
administration. Retention times were 3.22 min for fentanyl and 3.28 min for 
flurazepam. The plasma peak ratio (area of fentanyl divided by the internal standard 
area) produced a linear curve for the concentration range 0.1-25 ng/mL with a 
correlation coefficient of >0.99 (Table 1), and having a LOD of 0.05 ng/mL and LOQ 
of 0.1 ng/ml. Intra- and inter-day assay relative standard deviation (RSD) for plasma 
spiked with fentanyl were used to determine accuracy and precision which ranged 
from 2.6% to 8.2% (Table 2). The precision was found to be below ± 15% for all 
quality control samples. The average recovery for fentanyl was 100%. Stability of 
fentanyl under freeze-thaw conditions was tested and resulted in an average 2% loss 
after three cycles (Table 3). 
In conclusion, this HPLC method quantifies fentanyl from plasma by combining a 
liquid extraction procedure with mass spectroscopy. This analytical procedure was 
validated in terms of recovery, linearity, LOQ, precision, and accuracy. This method 
utilizes a small sample size of 100 µL making it potentially useful for small dogs, cats 
or other small animals. Fig 3 is a representative concentration-time profile from a 
fentanyl pharmacokinetic study.
Assay linearity (n=5)
Mean  ± STD RSD (%)
Slope 0.1749 ± 0.0062 3.5
Y-intercept 0.0047 ± 0.0003 6.19
R2 0.9996 ± 0.0002 0.02
Table 1. Fentanyl assay linearity Table 2.  Intra-assay and Inter-assay 
accuracy and precision for fentanyl  in 
plasma.
Chromatographic Conditions
The analysis of fentanyl in plasma was conducted using reverse phase HPLC. The       
chromatography system consisted of a 2695 separation module and an Acuity QDa 
single-quadrupole mass detector (Waters). Separation was achieved on a Waters 
XBridge C18 column (2.1 x 50 mm, 3.5 µm) preceded by a XBridge C18 guard column. 
Table 3: Fentanyl freeze-thaw stability
Figure 3: Pharmacokinetic profile of fentanyl in canine plasma
Figure 2
Chromatograms for Flurazepam (I.S.) in K9 
plasma
A: Blank K9 plasma sample
B: Spiked 2.5 ng/ml K9 plasma standard
C: Canine plasma sample Sherman 90 min 
after fentanyl administration
Figure 1
Chromatograms for Fentanyl in K9 plasma
A: Blank K9 plasma sample
B: Spiked 2.5 ng/ml K9 plasma standard
C: Canine plasma sample Sherman 90 min after 
fentanyl administration
Chromatographic Conditions
The mobile phase was a mixture of (A): water with 0.1% formic acid and (B) 
acetonitrile with 0.1% formic acid. The mixture  was pumped at a starting gradient of 
90% A and 10% B and was adjusted to 10% A and 90% B over 4 min, and back to 
initial conditions over 4 min.  The flow rate was 0.60 ml/min, and the column 
temperature was ambient which was 30˚C. The compounds were detected by positive 
selected ion recording (SIR). The scan rate was 2 pts/s, gain 1, capillary voltage 0.8 kV, 
cone voltage 15, ion source temperature 150˚C and probe temperature 600˚C. 
Nitrogen was used as the nebulizing gas. Fentanyl was detected at 337.34 m/z and 
flurazepam was detected at 388.24 m/z.
SD, standard deviation; n, number of days or samples
